Synthesis of sugar arrays in microtiter plate.

PubWeight™: 1.96‹?› | Rank: Top 2%

🔗 View Article (PMID 12452714)

Published in J Am Chem Soc on December 04, 2002

Authors

Fabio Fazio1, Marian C Bryan, Ola Blixt, James C Paulson, Chi-Huey Wong

Author Affiliations

1: Department of Chemistry and Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.

Articles citing this

Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc Natl Acad Sci U S A (2004) 7.55

Glycoproteomic probes for fluorescent imaging of fucosylated glycans in vivo. Proc Natl Acad Sci U S A (2006) 2.70

Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12. Proc Natl Acad Sci U S A (2005) 2.50

Glycan microarrays for decoding the glycome. Annu Rev Biochem (2011) 1.81

Highly efficient chemoenzymatic synthesis of naturally occurring and non-natural alpha-2,6-linked sialosides: a P. damsela alpha-2,6-sialyltransferase with extremely flexible donor-substrate specificity. Angew Chem Int Ed Engl (2006) 1.76

"Clicking" functionality onto electrode surfaces. Langmuir (2004) 1.65

Mixed azide-terminated monolayers: a platform for modifying electrode surfaces. Langmuir (2006) 1.57

Photocleavable fluorescent nucleotides for DNA sequencing on a chip constructed by site-specific coupling chemistry. Proc Natl Acad Sci U S A (2004) 1.55

One-pot three-enzyme chemoenzymatic approach to the synthesis of sialosides containing natural and non-natural functionalities. Nat Protoc (2006) 1.42

Carbohydrate microarray for profiling the antibodies interacting with Globo H tumor antigen. Proc Natl Acad Sci U S A (2005) 1.34

Heterocyclic peptide backbone modifications in an alpha-helical coiled coil. J Am Chem Soc (2004) 1.33

Glycan microarray of Globo H and related structures for quantitative analysis of breast cancer. Proc Natl Acad Sci U S A (2008) 1.33

Small-molecule microarrays as tools in ligand discovery. Chem Soc Rev (2008) 1.23

Engineering nanomaterial surfaces for biomedical applications. Exp Biol Med (Maywood) (2009) 1.21

Synthesis and microcontact printing of dual end-functionalized mucin-like glycopolymers for microarray applications. Angew Chem Int Ed Engl (2009) 1.18

Biocompatible carbon nanotubes generated by functionalization with glycodendrimers. Angew Chem Int Ed Engl (2008) 1.12

Microarrays in glycoproteomics research. Clin Lab Med (2009) 1.07

Electrochemically protected copper(I)-catalyzed azide-alkyne cycloaddition. Chembiochem (2008) 0.99

Advancements in the mechanistic understanding of the copper-catalyzed azide-alkyne cycloaddition. Beilstein J Org Chem (2013) 0.91

Photo-click immobilization on quartz crystal microbalance sensors for selective carbohydrate-protein interaction analyses. Anal Chem (2010) 0.91

Photo-click immobilization of carbohydrates on polymeric surfaces--a quick method to functionalize surfaces for biomolecular recognition studies. Bioconjug Chem (2009) 0.91

Synthesis of C-4 and C-7 triazole analogs of zanamivir as multivalent sialic acid containing scaffolds. Carbohydr Res (2007) 0.89

Sugar Chips immobilized with synthetic sulfated disaccharides of heparin/heparan sulfate partial structure. Bioorg Med Chem Lett (2008) 0.89

Rapid and Facile Microwave-Assisted Surface Chemistry for Functionalized Microarray Slides. Adv Funct Mater (2011) 0.89

Strategies for the profiling, characterisation and detailed structural analysis of N-linked oligosaccharides. Glycoconj J (2012) 0.88

Array-assisted characterization of a fucosyltransferase required for the biosynthesis of complex core modifications of nematode N-glycans. J Biol Chem (2013) 0.86

Oxime-based linker libraries as a general approach for the rapid generation and screening of multidentate inhibitors. Nat Protoc (2012) 0.85

Stereoselective synthesis of light-activatable perfluorophenylazide-conjugated carbohydrates for glycoarray fabrication and evaluation of structural effects on protein binding by SPR imaging. Org Biomol Chem (2011) 0.84

Modular synthesis of N-glycans and arrays for the hetero-ligand binding analysis of HIV antibodies. Nat Chem (2016) 0.82

Photons to illuminate the universe of sugar diversity through bioarrays. Glycoconj J (2007) 0.82

Significant rate accelerated synthesis of glycosyl azides and glycosyl 1,2,3-triazole conjugates. Glycoconj J (2007) 0.80

One-pot multienzyme synthesis of Lewis x and sialyl Lewis x antigens. Curr Protoc Chem Biol (2012) 0.79

Two-step functionalization of oligosaccharides using glycosyl iodide and trimethylene oxide and its applications to multivalent glycoconjugates. Chemistry (2014) 0.78

Designing polymers with sugar-based advantages for bioactive delivery applications. J Control Release (2015) 0.77

Design and synthesis of versatile ganglioside probes for carbohydrate microarrays. Glycoconj J (2008) 0.77

Glyco-epitope Diversity: An Evolving Area of Glycomics Research and Biomarker Discovery. J Proteomics Bioinform (2014) 0.75

Developing an Efficient and General Strategy for Immobilization of Small Molecules onto Microarrays Using Isocyanate Chemistry. Sensors (Basel) (2016) 0.75

Glycoarray Technologies: Deciphering Interactions from Proteins to Live Cell Responses. Microarrays (Basel) (2016) 0.75

Towards understanding the kinetic behaviour and limitations in photo-induced copper(i) catalyzed azide-alkyne cycloaddition (CuAAC) reactions. Phys Chem Chem Phys (2016) 0.75

Theoretical investigations on the stability of alkali metal substituted phenylpentazole. J Mol Model (2016) 0.75

Articles by these authors

Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature (2011) 11.07

Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science (2006) 10.04

Siglecs and their roles in the immune system. Nat Rev Immunol (2007) 7.98

Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc Natl Acad Sci U S A (2004) 7.55

Recognition of bacterial glycosphingolipids by natural killer T cells. Nature (2005) 6.38

Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol (2005) 6.17

Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol (2006) 5.51

A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. Science (2011) 5.44

Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med (2007) 4.47

Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. Nat Chem Biol (2006) 4.20

Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science (2008) 4.11

New world bats harbor diverse influenza A viruses. PLoS Pathog (2013) 4.10

Characterization of H7N9 influenza A viruses isolated from humans. Nature (2013) 3.71

Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. Nat Immunol (2005) 3.70

Probing the dynamics of O-GlcNAc glycosylation in the brain using quantitative proteomics. Nat Chem Biol (2007) 3.60

Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria. Nat Immunol (2011) 3.48

Contemporary North American influenza H7 viruses possess human receptor specificity: Implications for virus transmissibility. Proc Natl Acad Sci U S A (2008) 3.45

In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity. Virology (2011) 3.19

Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120. Nat Struct Mol Biol (2013) 3.11

Recent avian H5N1 viruses exhibit increased propensity for acquiring human receptor specificity. J Mol Biol (2008) 3.00

Replication and transmission of H9N2 influenza viruses in ferrets: evaluation of pandemic potential. PLoS One (2008) 2.86

Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR. Nat Struct Mol Biol (2004) 2.83

Glycan microarray technologies: tools to survey host specificity of influenza viruses. Nat Rev Microbiol (2006) 2.83

CLEC5A is critical for dengue-virus-induced lethal disease. Nature (2008) 2.79

Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells. Proc Natl Acad Sci U S A (2007) 2.78

Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease. Proc Natl Acad Sci U S A (2002) 2.71

Glycoproteomic probes for fluorescent imaging of fucosylated glycans in vivo. Proc Natl Acad Sci U S A (2006) 2.70

Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycans. PLoS Pathog (2013) 2.66

Sweet spots in functional glycomics. Nat Chem Biol (2006) 2.50

Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12. Proc Natl Acad Sci U S A (2005) 2.50

A general strategy for the chemoenzymatic synthesis of asymmetrically branched N-glycans. Science (2013) 2.49

High-efficiency labeling of sialylated glycoproteins on living cells. Nat Methods (2009) 2.46

Glycans on influenza hemagglutinin affect receptor binding and immune response. Proc Natl Acad Sci U S A (2009) 2.31

Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses. Virology (2011) 2.28

Glycan array screening reveals a candidate ligand for Siglec-8. J Biol Chem (2004) 2.24

Homomultimeric complexes of CD22 in B cells revealed by protein-glycan cross-linking. Nat Chem Biol (2005) 2.22

Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity. J Exp Med (2005) 2.18

Sulfatases: structure, mechanism, biological activity, inhibition, and synthetic utility. Angew Chem Int Ed Engl (2004) 2.18

In vivo targeting of B-cell lymphoma with glycan ligands of CD22. Blood (2010) 2.17

Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. Proc Natl Acad Sci U S A (2005) 2.13

Frontiers in glycomics: bioinformatics and biomarkers in disease. An NIH white paper prepared from discussions by the focus groups at a workshop on the NIH campus, Bethesda MD (September 11-13, 2006). Proteomics (2008) 2.09

Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN. Proc Natl Acad Sci U S A (2008) 2.09

Glycomics: an integrated systems approach to structure-function relationships of glycans. Nat Methods (2005) 2.06

Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand. Glycobiology (2005) 2.06

Cell surface biology mediated by low affinity multivalent protein-glycan interactions. Curr Opin Chem Biol (2004) 2.05

Hemagglutinin-neuraminidase balance confers respiratory-droplet transmissibility of the pandemic H1N1 influenza virus in ferrets. Proc Natl Acad Sci U S A (2011) 2.04

Siglecs as targets for therapy in immune-cell-mediated disease. Trends Pharmacol Sci (2009) 2.04

Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens. J Biol Chem (2008) 2.02

Natural Sphingomonas glycolipids vary greatly in their ability to activate natural killer T cells. Chem Biol (2008) 1.95

HIV-1 protease: mechanism and drug discovery. Org Biomol Chem (2003) 1.90

Sulfotransferases: structure, mechanism, biological activity, inhibition, and synthetic utility. Angew Chem Int Ed Engl (2004) 1.86

Seromic profiling of colorectal cancer patients with novel glycopeptide microarray. Int J Cancer (2011) 1.84

Distinct endocytic mechanisms of CD22 (Siglec-2) and Siglec-F reflect roles in cell signaling and innate immunity. Mol Cell Biol (2007) 1.84

Glycan microarrays for decoding the glycome. Annu Rev Biochem (2011) 1.81

Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes. Cancer Res (2010) 1.79

Functional balance of the hemagglutinin and neuraminidase activities accompanies the emergence of the 2009 H1N1 influenza pandemic. J Virol (2012) 1.76

Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome. Nat Chem Biol (2012) 1.70

Sialoside specificity of the siglec family assessed using novel multivalent probes: identification of potent inhibitors of myelin-associated glycoprotein. J Biol Chem (2003) 1.68

Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles. Chem Biol (2005) 1.68

Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d. Proc Natl Acad Sci U S A (2006) 1.66

Efficient and stereoselective synthesis of α(2→9) oligosialic acids: from monomers to dodecamers. Angew Chem Int Ed Engl (2011) 1.65

High-affinity ligand probes of CD22 overcome the threshold set by cis ligands to allow for binding, endocytosis, and killing of B cells. J Immunol (2006) 1.65

Stable benzotriazole esters as mechanism-based inactivators of the severe acute respiratory syndrome 3CL protease. Chem Biol (2006) 1.63

Structural characterization of the hemagglutinin receptor specificity from the 2009 H1N1 influenza pandemic. J Virol (2011) 1.62

Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids. Proc Natl Acad Sci U S A (2007) 1.62

A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin. Nat Struct Mol Biol (2013) 1.60

Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9. J Biol Chem (2004) 1.60

A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses. Proc Natl Acad Sci U S A (2008) 1.59

Isofagomine- and 2,5-anhydro-2,5-imino-D-glucitol-based glucocerebrosidase pharmacological chaperones for Gaucher disease intervention. J Med Chem (2007) 1.58

Tailored glycoproteomics and glycan site mapping using saccharide-selective bioorthogonal probes. J Am Chem Soc (2007) 1.56

Crystal structure of the membrane-bound bifunctional transglycosylase PBP1b from Escherichia coli. Proc Natl Acad Sci U S A (2009) 1.55

The core trisaccharide of an N-linked glycoprotein intrinsically accelerates folding and enhances stability. Proc Natl Acad Sci U S A (2009) 1.54

The antioxidant protein alkylhydroperoxide reductase of Helicobacter pylori switches from a peroxide reductase to a molecular chaperone function. Proc Natl Acad Sci U S A (2006) 1.54

Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells. Proc Natl Acad Sci U S A (2011) 1.53

A potent and highly selective inhibitor of human alpha-1,3-fucosyltransferase via click chemistry. J Am Chem Soc (2003) 1.53

Conserved and heterogeneous lipid antigen specificities of CD1d-restricted NKT cell receptors. J Immunol (2006) 1.52

Glycan arrays: biological and medical applications. Curr Opin Chem Biol (2008) 1.52

Quantitative analysis of carbohydrate-protein interactions using glycan microarrays: determination of surface and solution dissociation constants. J Am Chem Soc (2007) 1.52

Structure, receptor binding, and antigenicity of influenza virus hemagglutinins from the 1957 H2N2 pandemic. J Virol (2009) 1.50

A focused microarray approach to functional glycomics: transcriptional regulation of the glycome. Glycobiology (2005) 1.49

Structure-based discovery of glycolipids for CD1d-mediated NKT cell activation: tuning the adjuvant versus immunosuppression activity. J Am Chem Soc (2006) 1.47

O-glycosylation modulates proprotein convertase activation of angiopoietin-like protein 3: possible role of polypeptide GalNAc-transferase-2 in regulation of concentrations of plasma lipids. J Biol Chem (2010) 1.46

Directed evolution of N-acetylneuraminic acid aldolase to catalyze enantiomeric aldol reactions. Bioorg Med Chem (2003) 1.44

Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo. J Exp Med (2009) 1.44

Hemagglutinin homologue from H17N10 bat influenza virus exhibits divergent receptor-binding and pH-dependent fusion activities. Proc Natl Acad Sci U S A (2013) 1.44

Macrolactamization of glycosylated peptide thioesters by the thioesterase domain of tyrocidine synthetase. Chem Biol (2004) 1.44

Retracted A new strategy for the synthesis of glycoproteins. Science (2004) 1.44

Expression of Globo H and SSEA3 in breast cancer stem cells and the involvement of fucosyl transferases 1 and 2 in Globo H synthesis. Proc Natl Acad Sci U S A (2008) 1.43

Sialoside analogue arrays for rapid identification of high affinity siglec ligands. J Am Chem Soc (2008) 1.42